PARIS — The AstraZeneca vaccine ought to solely be administered to these older than 55 years of age, in line with the most recent review by the French nationwide well being company unveiled on Friday.
The authority’s suggestion provides to the confusion within the nation only a day after French Prime Minister Jean Castex introduced that AstraZeneca vaccinations would restart following recommendation from the European Medicines Company that the vaccine was “protected and efficient.”
Castex himself, who’s simply 55, is because of obtain the jab Friday afternoon in an effort by the federal government to revive confidence within the vaccine.
The well being authority justified the choice by mentioning that each one three French sufferers who’ve suffered blood clots after receiving the vaccine had been youthful than 55 years outdated.
To this present day, there isn’t any established causality between the vaccine and these blood clots, however well being authorities have erred on the aspect of maximum warning in Europe.
The European Medicines Company (EMA) as soon as once more Thursday cleared the vaccine to be used with out age limits, describing it as “protected and efficient.”
That is the third time French authorities have modified their suggestion about tips on how to use the AstraZeneca vaccine.
In early February it had really helpful it to be used just for these youthful than 65 years of age. Then in early March, it reversed course and really helpful it to be used within the normal grownup inhabitants.
On Monday, French President Emmanuel Macron introduced France was suspending using the vaccine, “out of an abundance of warning,” after Germany and different European nations did too. The German well being ministry stated it suspended it following three deaths from unexplained blood clots in some sufferers who had been vaccinated.
Since then, the EMA cleared the vaccine once more.
The AstraZeneca vaccine is simpler to retailer and administer than different vaccines and is meant to be a central pillar of efforts to hurry up a lagging vaccination roll-out in France.
Greater than 50 p.c of the French inhabitants does not wish to get the AstraZeneca jab, in line with a ballot by Odoxa for Spine Consulting, Le Figaro and franceinfo.